# Isotretinoin for Proliferative Vitreoretinopathy

> **NCT01445028** · PHASE4 · COMPLETED · sponsor: **Wills Eye** · enrollment: 109 (actual)

## Conditions studied

- Proliferative Vitreoretinopathy

## Interventions

- **DRUG:** Isotretinoin

## Key facts

- **NCT ID:** NCT01445028
- **Lead sponsor:** Wills Eye
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-08
- **Final completion:** 2015-08
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2018-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01445028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01445028, "Isotretinoin for Proliferative Vitreoretinopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01445028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*